Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PP London Sumatra Indonesia Tbk. (LSIP) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

PP London Sumatra Indonesia Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

PP London Sumatra Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? PP London Sumatra Indonesia Tbk. trades at Rp1,335 (market cap 9.04T, 3.96M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is the larger of the two by market cap, and PP London Sumatra Indonesia Tbk. is more actively traded (3.96M versus 1.77M). Which is the better fit depends on your goals.

LSIPTSPC
Market Cap
9.04T11.36T
Volume
3.96M1.77M
Lot
39.64K17.71K
Turnover
5.28B4.61B
Average Price
1,333.352,603.9
Value
5.28B4.61B
Indicative Equilibrium Price
1,3352,590
Indicative Equilibrium Volume
139300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LSIP
View details
TSPC
View details

About PP London Sumatra Indonesia Tbk.

PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.

Read more on LSIP

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC